A Study of SU11248 In Patients With Metastatic Breast Cancer Who Have Failed Selected Other Therapies.

Irinotecan in Patients With Advanced Metastatic Breast Cancer Who Have Experienced Failure of an Anthracycline, a Taxane, and Capecitabine

NCT00072852 ·Status: COMPLETED ·Phase: PHASE2

Alpelisib And Sacituzumab Govitecan For Treatment Of Breast Cancer

NCT05143229 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE1

Phase II Study of Simvastatin in Primary Breast Cancer; Test of Its Potential Selectivity on Basal Subtype Breast Cancer

NCT00807950 ·Status: UNKNOWN ·Phase: PHASE2

Study to Evaluate the Safety and Efficacy of NKTR-102 in Patients With Metastatic or Locally Advanced Breast Cancer

NCT00802945 ·Status: COMPLETED ·Phase: PHASE2

Sequential Versus Simultaneous Use of Vinorelbine and Capecitabine in Patients With Metastatic Breast Cancer (MBC)

NCT00629148 ·Status: COMPLETED ·Phase: PHASE2

Clinical Trial of Alpelisb and Tucatinib in Patients With PIK3CA-Mutant HER2+ Metastatic Breast Cancer.

NCT05230810 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE1/PHASE2

Navelbine and Capecitabine in the Treatment of Metastatic Breast Cancer

NCT00153907 ·Status: COMPLETED ·Phase: PHASE1

1st or 2nd Line MBC (Metastatic Breast Cancer) With Previous Avastin (Bevacizumab) Therapy

NCT00493636 ·Status: COMPLETED ·Phase: PHASE2

Open-Label Umbrella Study To Evaluate Safety And Efficacy Of Elacestrant In Various Combination In Participants With Metastatic Breast Cancer

NCT05563220 ·Status: RECRUITING ·Phase: PHASE1/PHASE2

A Study of Ispinesib in Metastatic Breast Cancer

NCT00607841 ·Status: TERMINATED ·Phase: PHASE1

Capecitabine and Pseudomonas Aeruginosa Combination in Metastatic Breast Cancer (MBC)

NCT01380808 ·Status: COMPLETED ·Phase: PHASE2

A Study of Rucaparib Administered With Radiation in Patients With Triple Negative Breast Cancer With an Incomplete Response Following Chemotherapy

NCT03542175 ·Status: COMPLETED ·Phase: PHASE1

A Phase II Trial of Abraxane™ Given Weekly as a Single Agent in First-line Treatment of Metastatic Breast Cancer

NCT00251472 ·Status: COMPLETED ·Phase: PHASE2

A Notch Signalling Pathway Inhibitor for Patients With Advanced Breast Cancer (0752-014)

NCT00106145 ·Status: COMPLETED ·Phase: PHASE1

An Observational Study of Avastin (Bevacizumab) in Patients With Metastatic Breast Cancer

NCT01215123 ·Status: COMPLETED

Safety and Tolerability of MSI-1436C in Metastatic Breast Cancer

NCT02524951 ·Status: TERMINATED ·Phase: PHASE1

Suramin and Paclitaxel in Treating Women With Stage IIIB-IV Breast Cancer

NCT00054028 ·Status: COMPLETED ·Phase: PHASE1/PHASE2

Phase 1b/2 Study of BKM120 Plus Trastuzumab in Patients With HER2-positive Breast Cancer

NCT01132664 ·Status: TERMINATED ·Phase: PHASE1/PHASE2

A Phase Ib/II Study of BEZ235 and Trastuzumab in Patients With HER2-positive Breast Cancer Who Failed Prior to Trastuzumab

NCT01471847 ·Status: COMPLETED ·Phase: PHASE1

Phase II Trial of Weekly or Every 3-week Ixabepilone for Patients With Metastatic Breast Cancer

NCT00593827 ·Status: COMPLETED ·Phase: PHASE2

Study Evaluating the Safety and Efficacy of Onartuzumab And/or Bevacizumab in Combination With Paclitaxel in Participants With Metastatic, Triple Negative Breast Cancer

NCT01186991 ·Status: COMPLETED ·Phase: PHASE2

Trastuzumab and Oxaliplatin in Patients With Metastatic Breast Cancer

NCT00297596 ·Status: COMPLETED ·Phase: PHASE2

A Study to Assess the Safety and Efficacy of the VEGFR-FGFR-PDGFR Inhibitor, Lucitanib, Given to Patients With Metastatic Breast Cancer

NCT02202746 ·Status: TERMINATED ·Phase: PHASE2

Capecitabine as NeoAdjuvant Therapy in Locally Advanced Breast Cancer

NCT00347438 ·Status: TERMINATED ·Phase: PHASE2

First Line Therapy for Patients With Metastatic Breast Cancer

NCT00456846 ·Status: TERMINATED ·Phase: PHASE2